PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Neurotransmitters resarch can promote better drugs for brain disorders

Hebrew University scientists decipher mechanism

2014-01-07
(Press-News.org) Contact information: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Neurotransmitters resarch can promote better drugs for brain disorders Hebrew University scientists decipher mechanism

Jerusalem, January 7, 2014 -- Although drugs have been developed that inhibit the imbalance of neurotransmitters in the brain – a condition which causes many brain disorders and nervous system diseases – the exact understanding of the mechanism by which these drugs work has not yet been fully explained.

Now, researchers at the Hebrew University of Jerusalem, using baker's yeast as a model, have deciphered the mode by which the inhibitors affect the neurological transmission process and have even been able to manipulate it.

Their work, reported in a recent article in the Journal of Biological Chemistry, raises hopes that these insights could eventually guide clinical scientists to develop new and more effective drugs for brain disorders associated with neurotransmitter imbalance.

All of the basic tasks of our existence are executed by the brain – whether it is breathing, heartbeat, memory building or physical movements – which depend on the highly regulated and efficient release of neurotransmitters – chemicals that act as messengers enabling extremely rapid connections between the neurons in the brain.

When even one part of the everyday "conversation" between neighboring neurons breaks down, the results can be devastating. Many brain disorders and nervous system diseases, including Huntington's disease, various motor dysfunctions and even Parkinson's disease, have been linked to problems with neurotransmitter transport.

The neurotransmitters are stored in the neuron in small, bubble-like compartments, called vesicles, containing transport proteins that are responsible for the storage of the neurotransmitters into the vesicles.

The storage of certain neurotransmitters is controlled by what is called the vesicular monoamine transporter (VMAT), which is known to transport a variety of vital neurotransmitters, such as adrenaline, dopamine and serotonin.

In addition, it can also transport the detrimental MPP+, a neurotoxin involved in models of Parkinson's disease.

A number of studies demonstrated the significance of VMAT as a target for drug therapy in a variety of pathologic states, such as high blood pressure, hyperkinetic movement disorders and Tourette syndrome.

Many of the drugs that target VMAT act as inhibitors, including the classical VMAT2 inhibitor, tetrabenazine. Tetrabenazine has long been used for the treatment of motor dysfunctions associated with Huntington's disease and other movement disorders. However, the mechanism by which the drug affects the storage of neurotransmitters was not fully understood.

The Hebrew University study set out, therefore, to achieve an understanding of the basic biochemical mechanism underlying the VMAT reaction, with a view towards better controlling it through new drug designs.

The research was conducted by in the laboratory of Prof. Shimon Schuldiner of the Hebrew University's Department of Biological Chemistry; Dr.Yelena Ugolev, postdoctoral fellow in the laboratory; and research students Tali Segal, Dana Yaffe and Yael Gros.

To identify protein sequences responsible for tetrabenazine binding, the Hebrew University scientists harnessed the power of yeast genetics along with the method of directed evolution.

Expressing the human protein VMAT in baker's yeast cells confers them with the ability to grow in the presence of toxic substrates, such as neurotoxin MPP+. Directed evolution mimics natural evolution in the laboratory and is a method used in protein engineering.

By using rounds of random mutations targeted to the gene encoding the protein of interest, the proteins can be tuned to acquire new properties or to adapt to new functions or environment.

The study led to identification of important flexible domains (or regions) in the structure of the VMAT, responsible for producing optional rearrangements in tetrabenazine binding, and also enabling regulation of the velocity of the neurotransmitter transporter.

Utilizing these new, controllable adaptations could serve as a guide for clinical scientists to develop more efficient drugs for brain disorders associated with neurotransmitter imbalance, say the Hebrew University researchers.



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

The 5 fingers of our feathered friends: New research results on the evolution of bird wings

2014-01-07
The 5 fingers of our feathered friends: New research results on the evolution of bird wings In most tetrapods (land vertebrates) the fourth (ring) finger is the first to develop in the embryo. And in birds, the finger on the outside of the hand (posterior, ...

Gemini Planet Imager first light

2014-01-07
Gemini Planet Imager first light World's most powerful exoplanet camera turns its eye to the sky This news release is available in Spanish. After nearly a decade of development, construction, and testing, the world's most advanced instrument for directly imaging ...

To keep their eye on the ball, batters mostly use their heads

2014-01-07
To keep their eye on the ball, batters mostly use their heads How do hitters track pitches in baseball? Study in optometry and vision science gives new insights Philadelphia, Pa. (January 7, 2014) - Baseball players at bat follow coaches' advice to "keep ...

New algorithm can dramatically streamline solutions to the 'max flow' problem

2014-01-07
New algorithm can dramatically streamline solutions to the 'max flow' problem Research could boost the efficiency even of huge networks like the Internet Finding the most efficient way to transport items across a network like the U.S. highway system or the ...

When germs attack: A lens into the molecular dance

2014-01-07
When germs attack: A lens into the molecular dance Researchers at Johns Hopkins have zoomed in on what is going on at the molecular level when the body recognizes and defends against an attack of pathogens, and the findings, they say, could influence how drugs are ...

Synthetic genetic clock checks the thermometer

2014-01-07
Synthetic genetic clock checks the thermometer Rice University leads study to counter effects of temperature on synthetic gene circuits HOUSTON – (Jan. 7, 2014) – Genetic systems run like clockwork, attuned to temperature, time of day and many other factors as they regulate ...

Dabrafenib in melanoma: Added benefit not proven

2014-01-07
Dabrafenib in melanoma: Added benefit not proven No differences could be shown for mortality, symptoms and quality of life / concerning side effects, data too uncertain Dabrafenib (trade name: Tafinlar) has been approved in Germany ...

Aflibercept in macular oedema: Added benefit not proven

2014-01-07
Aflibercept in macular oedema: Added benefit not proven Neither the new drug nor the comparator therapy was used in accordance with their approvals in the studies For the third time in one year, the German Institute for Quality ...

Increased risk of prostate cancer in African American men; implications for PSA screening

2014-01-07
Increased risk of prostate cancer in African American men; implications for PSA screening New Rochelle, NY, January 7, 2014—African American men have an increased risk of prostate cancer and are two times more likely than Caucasian American ...

Sugar-burning in the adult human brain is associated with continued growth, and remodeling

2014-01-07
Sugar-burning in the adult human brain is associated with continued growth, and remodeling Research published in the journal Cell Metabolism shows that hotspots of fuel consumption in the adult brain also show key characteristics of developing brain regions SEATTLE, ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Neurotransmitters resarch can promote better drugs for brain disorders
Hebrew University scientists decipher mechanism